Contract 75F40120C00158
Cerus Corporation · Department Of Health And Human Services · September 24, 2020
Cerus Corporation was awarded a federal contract by Department Of Health And Human Services (Food And Drug Administration) on September 24, 2020 for $11.11 million of work in pharmaceutical preparation manufacturing. Performance is in Concord, CA. It was awarded under full and open competition. The contract has been modified 1 time since the base award It uses cost no fee contract pricing. The most recent modification was on July 24, 2025.
Contract details
- PIID
- 75F40120C00158
- Award type
- Definitive Contract
- Pricing
- Cost No Fee
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Health R&D Services; Health Care Services; Basic Research
- Place of performance
- Concord, CA
- First action
- September 24, 2020
- Latest action
- July 24, 2025
Description
BAA PROPOSAL EETWP33 DEVELOPMENT OF AN OPTIMIZED PATHOGEN INACTIVATION PROCESS FOR WHOLE BLOOD, COR CHANGE
Modification timeline
-
July 24, 2025Mod P00004 · Other Administrative Action$11.11M
-
September 24, 2020Base awardBAA PROPOSAL EETWP33 DEVELOPMENT OF AN OPTIMIZED PATHOGEN INACTIVATION PROCESS FOR WHOLE BLOOD$11.11M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Phlow Corp. | Department Of Health And Human Services | July 2, 2026 | $696.67M |
| Sri International | Department Of Health And Human Services | July 2, 2026 | $0 |
| Pfizer Inc | Department Of Health And Human Services | June 29, 2026 | $1.12B |
| Kymanox Corp | Department Of Health And Human Services | June 25, 2026 | $0 |
| Mckesson Specialty Distribution Llc | Department Of Health And Human Services | June 24, 2026 | $203.93M |
| Mriglobal | Department Of Health And Human Services | June 24, 2026 | $514.9K |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 1,187 | $4.96B |
| 2 | Merck Sharp & Dohme Llc | 26 | $894.71M |
| 3 | Sanofi Vaccines Us Inc. | 57 | $702.38M |
| 4 | Pfizer Inc | 169 | $541.15M |
| 5 | Glaxosmithkline, Llc | 14 | $505.04M |
| 6 | Phlow Corp. | 1 | $105.27M |
| 7 | Exelan Pharmaceuticals Inc | 76 | $104.30M |
| 8 | Seqirus USA Inc | 47 | $59.15M |
| 9 | Emergent Biosolutions Canada Inc | 2 | $53.73M |
| 10 | Mckesson Specialty Distribution Llc | 1 | $51.05M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75F40120C00158?
Contract 75F40120C00158 is a federal contract awarded to Cerus Corporation by Department Of Health And Human Services on September 24, 2020 for $11.11 million of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 1 time since the base award.
Who won contract 75F40120C00158?
Cerus Corporation won contract 75F40120C00158 from Department Of Health And Human Services.
How much is contract 75F40120C00158 worth?
Contract 75F40120C00158 has obligated $11.11 million to date.